ContextVision announces appointment of Gerald Pötzsch as new CEO
ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Gerald Pötzsch as Chief Executive Officer, effective 1st of August 2022.
Gerald has solid academic and professional background, holding doctor’s degrees both in Engineering and Medicine and 16 years with Philips Medical imaging business. “This will be a good addition to the existing team at ContextVision and a good support for our successful development of ContextVision”, says Olof Sandén Chairman of ContextVision.
Gerald has had an international leadership career within Philips in multiple roles such as having worked in commercially leading roles in German speaking countries as well as in the Nordic countries. More recently he established global solution business areas that stretch across the existing Philips Business Units to integrate end-user requirements more clearly. His roles have taken Gerald across the world, having had roles in Europe, Asia-Pacific, and the US, where he has built a strong network of industry colleagues and clinicians.
“I am impressed by the unique position that ContextVision has in the medical imaging market. Not only do I see automated image processing continuously growing as a business, but I am particularly excited about its increasing relevance for effective and efficient healthcare as well as to the benefit of each patient. I am now looking forward to getting to know the ContextVision team and to engage further with their well renown customers. We have a clear path and exciting journey ahead of us.” says Gerald Pötzsch, incoming CEO.
Gerald is of German nationality and has lived in Sweden between 2010 - 2015 and has recently returned from the US to live in Stockholm with his family.
“I am very pleased that Gerald has joined the team at ContextVision, his experience from large imaging OEMs is a great addition and we are looking forward working with him to further strengthen ContextVision. I would also like to thank our present interim CEO Ola Lindblad, he has done a fantastic job to drive ContextVision in the interim period and deliver a strong Q1, says Olof Sandén”, Chairman of ContextVision.
-------------------------
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.
This information is information that ContextVision is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on May 13, 2022.
-------------------------
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world.
Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment.
The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.